Skip to main content

Lobular Breast Cancer

This special series takes a translational view of lobular breast cancer, from bedside to bench and back. The second most common breast cancer subtype, lobular breast cancer displays many unique molecular and clinical properties. Leaders in the field explore the molecular biology, pathology, risk factors, imaging, treatment and prognosis of this breast cancer.

Prof. Ulrich Lehmann. Hannover Medical School

  1. The limitations of mammography in the detection and evaluation of invasive lobular carcinoma (ILC) have long been recognized, presenting real clinical challenges in treatment planning for these tumors. However...

    Authors: Karen Johnson, Deba Sarma and E Shelley Hwang
    Citation: Breast Cancer Research 2015 17:94
  2. Lobular carcinoma in situ (LCIS) is considered to be a risk factor for the development of invasive breast carcinoma, but it may also be a non-obligate precursor to invasive lobular carcinoma (ILC). Many LCIS lesi...

    Authors: Greg J. Logan, David J. Dabbs, Peter C. Lucas, Rachel C. Jankowitz, Daniel D. Brown, Beth Z. Clark, Steffi Oesterreich and Priscilla F. McAuliffe
    Citation: Breast Cancer Research 2015 17:76